Context Bladder cancer (BC) represents a significant health problem due to the potential
morbidity and mortality associated with disease burden, which has remained largely …

Bladder cancer is a highly prevalent disease and is associated with substantial morbidity,
mortality and cost. Environmental or occupational exposures to carcinogens, especially …

Purpose: This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of …

Urothelial carcinoma of the bladder comprises two long-recognized disease entities with
distinct molecular features and clinical outcome. Low-grade non-muscle-invasive tumours …

CONTEXT: Urothelial bladder cancer (UBC) is a disease of significant morbidity and
mortality. It is important to understand the risk factors of this disease. OBJECTIVE: To …

Bladder cancer is one of the most common cancers worldwide, with transitional cell
carcinoma (TCC) being the predominant form. Here we report a genomic analysis of TCC by …

Advanced paternal age has been associated with an increased risk for spontaneous
congenital disorders and common complex diseases (such as some cancers, schizophrenia …

We conducted a multi-stage, genome-wide association study of bladder cancer with a
primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of …

Bladder cancer is mainly a disease of aging; its incidence and prevalence increase around
the sixth decade and peak in the seventh to eighth decade of life. It is the ninth most …

Background Genomic regions identified by genome-wide association studies (GWAS) for
bladder cancer risk provide new insights into etiology. Objective To identify new …